GT 3021
Latest Information Update: 23 Feb 1998
At a glance
- Originator Serono Genetics Institute
- Class Antivirals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 23 Feb 1998 Discontinued-I for Herpes simplex virus infections in France (Unknown route)
- 23 Feb 1998 Discontinued-Preclinical for Herpes simplex virus infections in USA (Unknown route)
- 08 Sep 1995 Preclinical development for Herpes simplex virus infections in USA (Unknown route)